← Back

$ Value

$0

Shares

3,549

Price

$0

Filed

May 8

Insider

Name

Bradner James E.

Title

EVP, R&D, & Chief Sci. Officer

CIK

0002005159

Roles

Officer

Transaction Details

Transaction Date

2025-05-06

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

29,753

Footnotes

The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. | These shares include 948 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. | These non-qualified stock options were granted pursuant to the Equity Incentive Plan and are exercisable in four equal annual installments of 25% each commencing on 5/6/2026.

Filing Info

Accession No.

0001127602-25-013778

Form Type

4

Issuer CIK

0000318154

Bradner James E.'s History

Date Ticker Type Value
2025-05-06 AMGN A $0
2025-05-06 AMGN A $6.2M

Other Insiders at AMGN (90d)

No other insider activity at this issuer in the last 90 days.